How to analyze the company?LEARNWhat should you know before buying?
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BR

NASDAQ:BRTX
Get a brief AI stock analysisSaves ~ 15 minutes of your time

BR

BioRestorative Therapies IncNASDAQ BRTX Stock Report

Get a brief AI stock analysis
Saves ~ 15 minutes of your time

Price

Market cap $B

Exchange

XNAS - Nasdaq

FAIR VALUE

Is BRTX undervalued compared to its fair value?

The fair value of BRTX stock is hidden USD. Relative to the market price of 1.65 USD BioRestorative Therapies Inc is hidden.

Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. The company is headquartered in Melville, New York and currently employs 7 full-time employees. The company went IPO on 2001-...[More about valuation]

BioRestorative Therapies Fair Value

hidden
UNLOCK
What is fair value?

Market cap:

0.011 $B

Price:

1.65 USD

Fair value:

hidden

Max value:

hidden

Min value:

hidden

P/E:

hidden

EPS:

-0.333

FINANCIALS

BioRestorative Therapies financial for reporting period

Income Statement

0 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0041 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0022 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
Revenue analysis

0 B 100%
-0.0041 B -11741%
-0.0022 B -6352%

Balance Sheet

0.018 B
0.015 B

Financial Position Analysis

Assets

0.018 B
Current Assets
0.017 B
Total non-current assets
0.0012 B

Total current liabilities
0.0034 B
Total non-current liabilities

Cash Flow Statement

-N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A
-0.0023 B N/A

Growth Rates:
1 yearN/A
3 yearsN/A
5 yearsN/A

BioRestorative Therapies fundamental analysis for trailing twelve months (TTM)

Profitability Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Solvency Indicators


Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Efficiency Indicators

-56 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%
-48 %

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Average:
1 yearundefined%
3 yearsundefined%
5 yearsundefined%

Dupont Analysis

Stability Indicators

STOCK ANALYSIS

Is BRTX attractive for investment based on fundamental analysis?

BRTX stock rating is hidden. BioRestorative Therapies is a hidden by Eyestock methodology.

Get BRTX Stock Rating
to complete you analysis
UNLOCK
Learn more about quality score?

Net Profit Margin:

-4 824

Gross Margin:

CFO / Debt ratio:

hidden

Current ratio:

6.773

Debt / Equity ratio:

ROE:

-56

ROIC:

hidden

Stability Ratio (2y):

hidden

Stability Ratio (5y):

hidden

Earnings quality:

hidden

BRTX analysis by AI

Eyebot AI analysis

We carefully consider 10 indicators for BRTX to calculate the final rating score. Use AI leverage to quickly get the main conclusions before diving into the details

BioRestorative Therapies Inc competitors

AB

ABBV

Abbvie Inc

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. The company is headquartered in North Chicago, Ill...

Discover

AM

AMGN

Amgen Inc

Amgen Inc. is a biotechnology company. The Company discovers, develops, manufactures and delivers various human therapeutics. It operates in human therapeutics segment. The Company...

Discover

VR

VRTX

Vertex Pharmaceuticals Inc

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs fo...

Discover

BioRestorative Therapies Inc dividends

BRTX dividend metrics

Payout ratio
Dividend yield
Annual dividend
Dividend streak
Average dividend yield over 3 years
Average dividend yield over 5 years

Dividend per share

By years
By payments
1y
3y
5y
All time
This ticker has no dividend history

About BRTX stock

About the company BioRestorative Therapies Inc

Market cap $B

0.011

Dividend yield

Shares outstanding

3.67363 B

Biorestorative Therapies Inc. provides stem cell collections, storage, and treatment services. The company is headquartered in Melville, New York and currently employs 7 full-time employees. The company went IPO on 2001-07-11. The company offers two developmental programs, namely Disc/Spine Program (brtxDisc) and Metabolic Program (ThermoStem), which relate to the treatment of disc/spinedisease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous hypoxic cultured mesenchymal stem cell (MSC) product derived from a patient's own bone marrow and formulated with a biomaterial carrier (platelet lysate). BRTX-100 is used for the non-surgical treatment of painful lumbosacral disc disorders or as a complimentary therapeutic to a surgical procedure. The company is engaged in developing a cell-based therapy candidate to target obesity and metabolic disorders using brown adipose (fat) derived stem cells (BADSC), to generate brown adipose tissue (BAT).

BRTX profile

  • Ticker

    BRTX

  • Country

    USA

  • Exchange

    XNAS - Nasdaq

  • Report currency

    USD - US dollar

  • IPO date

    11 July 2001

  • Sector

    Healthсare

  • Industry

    Biotechnology

  • Employees

    7

  • City

    Melville

  • Address

    40 Marcus Drive

  • Cusip

    090655606